What is the FIB-4 index?

The FIB-4 index (Fibrosis-4) is a validated non-invasive blood test formula that estimates the likelihood of advanced liver fibrosis (bridging fibrosis F3 or cirrhosis F4) using age, AST, ALT, and platelet count. Published by Sterling et al. in Hepatology (2006), it is widely used across NAFLD, viral hepatitis (HBV, HCV), and chronic liver disease without requiring liver biopsy for initial screening.

How is FIB-4 calculated?

FIB-4 = (age × AST) ÷ (platelets × √ALT). Age in years, AST and ALT in U/L, platelets in ×10⁹/L (same numeric value as ×10³/µL). Example: age 55, AST 50, ALT 40, platelets 200 → FIB-4 = (55 × 50) ÷ (200 × √40) = 2750 ÷ 1264.91 = 2.174 (indeterminate zone).

What FIB-4 cutoffs indicate advanced fibrosis?

Standard cutoffs: FIB-4 2.67 rules in advanced fibrosis (positive predictive value ~65–80%); scores between 1.30 and 2.67 are indeterminate (~20–30% of patients) and require further testing such as FibroScan, NFS, or specialist assessment.

What does a low FIB-4 mean?

A low FIB-4 (below 1.30) suggests advanced fibrosis is unlikely. Most patients in this range have no or mild fibrosis (F0–F2). Continue lifestyle management—7–10% weight loss, Mediterranean diet, exercise—and routine liver enzyme monitoring. A low FIB-4 does not guarantee a healthy liver if steatosis or inflammation persists.

What does an indeterminate FIB-4 mean?

An indeterminate FIB-4 (1.30 to 2.67) cannot reliably exclude or confirm advanced fibrosis. Do not assume mild disease. Request transient elastography (FibroScan), NAFLD Fibrosis Score (NFS) comparison, or hepatology referral. About 20–30% of patients fall in this zone—additional non-invasive tests improve staging accuracy.

What does a high FIB-4 mean?

A high FIB-4 (above 2.67) indicates a high probability of bridging fibrosis (F3) or cirrhosis (F4). Prompt hepatology evaluation is recommended. Assess for portal hypertension, varices, and hepatocellular carcinoma surveillance if cirrhosis is confirmed. High FIB-4 is a screening result—not a biopsy replacement.

What labs do I need for the FIB-4 calculator?

You need: age, AST and ALT from liver function tests, and platelet count from a complete blood count (CBC). All are standard outpatient labs. Fasting is not required for FIB-4 itself. Use values from the same blood draw when possible for accurate staging.

What units should I use for platelets?

Platelets: enter as ×10⁹/L or ×10³/µL (same numeric value, e.g., 220). AST and ALT are in U/L. This calculator uses platelets in ×10⁹/L internally per the Sterling formula.

Why does age affect FIB-4 so much?

Age is multiplied by AST in the FIB-4 numerator, so older patients naturally score higher even without proportional fibrosis severity. In adults ≥65, a rule-in cutoff of > 2.0 (instead of 2.67) is often used to reduce false positives. Always interpret FIB-4 alongside clinical context and elastography in older adults.

What is the significance of AST/ALT ratio with FIB-4?

While FIB-4 uses AST and √ALT separately (not the ratio directly), AST/ALT ratio ≥ 1.0 often suggests fibrosis-related mitochondrial injury rather than pure steatosis, where ALT typically exceeds AST. Alcohol, muscle injury, and medications can also elevate AST independently—interpret alongside clinical history.

How accurate is the FIB-4 index?

In meta-analyses across NAFLD, HCV, and HBV cohorts, FIB-4 2.67 has ~65% sensitivity and ~88% specificity with positive predictive value ~65–80%. Accuracy varies by population—indeterminate results are common and elastography improves staging.

How is FIB-4 different from the NAFLD Fibrosis Score (NFS)?

FIB-4 uses only 4 inputs (age, AST, ALT, platelets) and is validated across multiple liver diseases. NFS adds BMI, diabetes/IFG, and albumin—7 inputs total—and is specifically validated for NAFLD/MASLD. Use NFS first in NAFLD when all labs are available; use FIB-4 when only basic labs exist or for concordant staging when NFS is indeterminate.

How is FIB-4 different from the Fatty Liver Risk Calculator?

Our Fatty Liver Risk Calculator screens lifestyle and metabolic risk for developing NAFLD/MASLD—it does not stage fibrosis. The FIB-4 Calculator uses blood tests to estimate advanced fibrosis probability in patients who already have liver disease or elevated enzymes. Use both: risk screening first, FIB-4 when you have lab results.

Can FIB-4 be used in viral hepatitis (HBV, HCV)?

Yes. FIB-4 was originally validated in HCV patients and is widely used in HBV and HCV chronic liver disease. Cutoffs are similar though population-specific validation may vary. Specialist-guided staging remains essential for treatment decisions (antiviral therapy, etc.).

Does FIB-4 work in lean NAFLD?

Yes, FIB-4 can be used in lean NAFLD (normal BMI with hepatic steatosis). Without BMI in the formula, metabolic context matters—pair with NFS when possible. Lean patients may have discordant FIB-4 and imaging; indeterminate scores warrant FibroScan.

When should I see a hepatologist?

See a hepatologist if FIB-4 is indeterminate (1.30–2.67) or high (> 2.67), if liver enzymes remain elevated after lifestyle changes, if ultrasound shows steatosis with metabolic risk factors, or if you have symptoms of advanced liver disease (fatigue, jaundice, ascites, easy bruising).

Can I use FIB-4 to monitor treatment response?

FIB-4 can be tracked over time after sustained weight loss, glycemic improvement, or MASH therapy—but changes are slow (months to years). Repeat at 12-month intervals alongside ALT/AST and specialist imaging. A falling FIB-4 supports fibrosis regression but does not replace elastography.

Is this FIB-4 calculator a medical diagnosis?

No. This calculator is an educational screening tool based on published formulas and cutoffs. It does not diagnose cirrhosis, replace liver biopsy, or substitute for specialist care. Always discuss results with your doctor or hepatologist before making treatment decisions.

What is the FIB-4 formula breakdown?

Numerator = age (years) × AST (U/L). Denominator = platelets (×10⁹/L) × √ALT (U/L). Higher age, higher AST, lower platelets, or lower ALT all increase FIB-4. The calculator shows √ALT and component values in your results for transparency.

How often should I recalculate FIB-4?

If FIB-4 rules out advanced fibrosis and you maintain lifestyle changes, recheck annually with routine LFTs and CBC. If indeterminate or high, follow hepatology guidance—typically repeat after 6–12 months of treatment or with each specialist visit. Do not recalculate during acute illness when enzymes may be transiently elevated.

Can FIB-4 be used in children or adolescents?

No. FIB-4 was validated in adults aged 18 and older. Paediatric liver disease requires specialist assessment and different staging tools. This calculator accepts ages 18–100 only.

What causes a falsely high FIB-4?

Advanced age (especially ≥65), elevated AST from muscle injury or alcohol, low platelets from non-liver causes, and very low ALT all mathematically raise FIB-4. Acute hepatitis flares, recent strenuous exercise, and certain medications can transiently elevate AST. Repeat labs when clinically stable before acting on a high score.

What causes a falsely low FIB-4?

Young age, normal AST with high ALT (typical of pure steatosis), and high platelet count lower FIB-4. A low score can miss early F2 fibrosis—do not ignore persistently elevated enzymes or ultrasound steatosis based on FIB-4 alone.

Should I get a FibroScan if FIB-4 is low?

Usually not. A low FIB-4 ( 2.67), or when clinical suspicion remains high despite a low score (e.g., thrombocytopenia, splenomegaly, ascites).

How does FIB-4 compare to APRI score?

APRI = (AST ÷ AST upper limit of normal) × 100 ÷ platelets. APRI uses only AST and platelets (no age or ALT) and is simpler but less accurate than FIB-4 in NAFLD meta-analyses. FIB-4 is generally preferred for initial fibrosis screening; APRI is sometimes used in resource-limited settings or viral hepatitis programmes.

Can weight loss lower my FIB-4 score?

Yes, over months to years. Sustained 7–10% weight loss reduces hepatic steatosis and inflammation, which can normalise ALT and AST and modestly lower FIB-4. Changes are gradual—recheck at 12-month intervals alongside specialist imaging rather than expecting rapid score drops.

Is FIB-4 affected by hepatitis B or C treatment?

Yes. Successful antiviral therapy for HBV or HCV can normalise transaminases and improve fibrosis over time, lowering FIB-4. FIB-4 was originally validated in HCV patients and remains useful for monitoring treatment response under hepatology supervision.

What is the difference between FIB-4 and ELF test?

FIB-4 uses four routine lab values available in any clinic. ELF (Enhanced Liver Fibrosis) measures proprietary blood markers (hyaluronic acid, PIIINP, TIMP-1) through specialist labs—more accurate in indeterminate cases but costlier and less widely available. ELF is typically ordered by hepatologists when FIB-4 and FibroScan are discordant.

Can I calculate FIB-4 from a home test kit?

No. FIB-4 requires professionally measured AST, ALT, and platelet count from a certified laboratory. Home finger-prick tests do not provide the accuracy needed for fibrosis staging. Use this calculator only with lab results from your doctor or diagnostic centre.

FIB-4 Liver Fibrosis Calculator

Calculate the FIB-4 index from age, AST, ALT, and platelet count. Screen for advanced liver fibrosis (F3–F4) in NAFLD, viral hepatitis, and chronic liver disease with validated cutoffs and exportable results.

Enter your details — results appear below after you calculate.

Demographics

Age (years)

Age is part of the FIB-4 formula — scores naturally rise after 65

Liver function & blood tests

AST (U/L)

Typical reference: 10–40 U/L

ALT (U/L)

Typical reference: 7–56 U/L · must be > 0 for √ALT

Platelet units

Platelet count (×10⁹/L)

Typical reference: 150–400 ×10⁹/L

How this FIB-4 Liver Fibrosis calculator works

This tool computes the FIB-4 index—a validated blood-based score for advanced liver fibrosis (F3–F4) per Sterling et al. Hepatology 2006. FIB-4 < 1.30 rules out advanced fibrosis (~90% NPV); FIB-4 > 2.67 rules it in (~65–80% PPV); scores between are indeterminate and need FibroScan, NFS comparison, or specialist review.

Enter age (years), AST and ALT (U/L), and platelet count (×10⁹/L or ×10³/µL) from your latest blood work. Only four values needed—no BMI, diabetes, or albumin required.

Results include FIB-4 value, formula component breakdown (√ALT, numerator, denominator), fibrosis category (rule out / indeterminate / rule in), AST/ALT ratio analysis, individual lab reference status, age-adjusted note for adults ≥65, health score, clinical interpretation, FibroScan referral guidance, and PDF export.

Pair with our NAFLD Fibrosis Score (NFS), Fatty Liver Risk, Metabolic Syndrome Risk, and Diabetes Risk calculators for broader metabolic liver context. This is an educational screening tool—not a diagnosis. Seek hepatology care for high or indeterminate FIB-4. Emergency care for jaundice, vomiting blood, or severe abdominal swelling.

Quick reference: FIB-4 < 1.30 rules out advanced fibrosis · 1.30 to 2.67 is indeterminate (needs FibroScan) · FIB-4 > 2.67 suggests F3–F4 fibrosis · Age ≥65: rule-in cutoff > 2.0 may apply. Scroll below for formula breakdown, worked examples, FIB-4 vs NFS, FibroScan cutoffs, clinical screening guidance, diet and treatment options, lab variable explanations, common mistakes, and 30 FAQs.

FIB-4 Liver Fibrosis Calculator – Advanced Fibrosis Screening

Millions search "FIB-4 calculator", "FIB-4 index", and "liver fibrosis score" each year. The FIB-4 index is a validated non-invasive formula that estimates the likelihood of advanced liver fibrosis (bridging fibrosis F3 or cirrhosis F4) using only four routine blood values: age, AST, ALT, and platelet count. No biopsy required for initial screening. Our free calculator applies the Sterling et al. Hepatology 2006 formula with published cutoffs, driver analysis, clinical interpretation, and exportable results.

Pair results with our NAFLD Fibrosis Score (NFS) Calculator, Fatty Liver Risk Calculator, Metabolic Syndrome Risk Calculator, and Diabetes Risk Calculator for comprehensive metabolic liver health assessment.

Why Calculate the FIB-4 Index?

Chronic liver disease—from NAFLD/MASLD to viral hepatitis—can progress silently to advanced fibrosis and cirrhosis. FIB-4 helps triage who needs urgent hepatology referral versus who can continue lifestyle management, with ~90% negative predictive value at the low cutoff and ~65–80% positive predictive value at the high cutoff depending on population.

1What You Enter

Demographics

Age — years (18–100); part of the FIB-4 numerator

Laboratory values

AST & ALT — U/L from liver panel
Platelet count — ×10⁹/L or ×10³/µL

Example (Rule out — low fibrosis risk)

Age 42, AST 32, ALT 45, platelets 250 → FIB-4 = (42 × 32) ÷ (250 × √45) = 0.801 — below 1.30, advanced fibrosis unlikely. Continue lifestyle optimization.

Example (Rule in — high fibrosis risk)

Age 62, AST 78, ALT 52, platelets 145 → FIB-4 = (62 × 78) ÷ (145 × √52) = 4.625 — above 2.67, high probability of advanced fibrosis. Hepatology referral advised.

Example (Indeterminate zone)

Age 55, AST 50, ALT 40, platelets 200 → FIB-4 = (55 × 50) ÷ (200 × √40) = 2.174 — indeterminate (1.30 to 2.67). Cannot rule out or confirm advanced fibrosis; request FibroScan, NFS comparison, and hepatology review.

2FIB-4 Formula & Cutoffs

FIB-4 = (age × AST) ÷ (platelets × √ALT)

Platelets in ×10⁹/L (same numeric value as ×10³/µL). AST and ALT in U/L. Age in years.

FIB-4 range	Interpretation	Action
< 1.30	Low probability of advanced fibrosis	Lifestyle care; routine monitoring
1.30 to 2.67	Indeterminate	FibroScan / NFS / hepatology referral
> 2.67	High probability of advanced fibrosis	Urgent specialist evaluation

Age ≥65: FIB-4 naturally rises with age. In older adults, a rule-in cutoff of > 2.0 (instead of 2.67) is often used to reduce false positives—discuss with your hepatologist.

3Understanding Liver Fibrosis Stages

Stage	Description	FIB-4 relevance
F0	No fibrosis; steatosis only	FIB-4 usually < 1.30
F1	Mild fibrosis	Often low FIB-4; may overlap indeterminate
F2	Moderate fibrosis	Indeterminate zone common
F3	Bridging fibrosis	FIB-4 often > 2.67
F4	Cirrhosis	High FIB-4; confirm with elastography

FIB-4 vs Other Fibrosis Tests

Test	Inputs	Best use
FIB-4 (this calculator)	Age, AST, ALT, platelets	First-line screening; only 4 routine labs needed
NAFLD Fibrosis Score (NFS)	Age, BMI, diabetes, AST, ALT, platelets, albumin	NAFLD-specific; adds metabolic variables
FibroScan	Ultrasound elastography (kPa)	Gold-standard non-invasive staging when FIB-4 indeterminate
Liver biopsy	Histology	Definitive diagnosis when non-invasive tests discordant

Treatment & Lifestyle When FIB-4 Is Elevated

7–10% weight loss — most effective intervention for early MASLD; reduces liver fat and can lower FIB-4 over 6–12 months
Mediterranean diet — limits fructose, refined carbs, and saturated fat; emphasizes olive oil, fish, vegetables
150+ min/week exercise — aerobic activity reduces hepatic steatosis independent of weight loss
Glycemic control — optimize HbA1c in diabetes; GLP-1 agonists show fibrosis benefits in trials
Avoid alcohol — even moderate intake worsens liver disease and elevates AST
Specialist therapies — resmetirom for F2–F3 MASH; hepatology-guided only

4How FIB-4 Is Calculated — Step by Step

Full formula

FIB-4 = (age × AST) ÷ (platelets × √ALT)

Age in years. AST and ALT in U/L. Platelets in ×10⁹/L (same numeric value as ×10³/µL). ALT must be > 0 for the square root.

What each variable contributes

Variable	Role in formula	Effect on FIB-4
Age (years)	Numerator (× AST)	Higher age raises FIB-4 — strongest in ≥65
AST (U/L)	Numerator (× age)	Higher AST raises FIB-4
Platelets (×10⁹/L)	Denominator	Lower platelets raise FIB-4 substantially
ALT (U/L)	Denominator (√ALT)	Lower ALT raises FIB-4 (smaller denominator)

Worked calculation (Indeterminate)

Age 55, AST 50, ALT 40, platelets 200 → Numerator = 55 × 50 = 2,750 → √ALT = √40 = 6.3246 → Denominator = 200 × 6.3246 = 1,264.91 → FIB-4 = 2,750 ÷ 1,264.91 = 2.174 (indeterminate). Compare with NFS if BMI, diabetes, and albumin are available.

FIB-4 Risk Categories — Rule Out, Indeterminate & Rule In

Category	FIB-4 cutoff	NPV / PPV	Typical fibrosis stage	Recommended action
Rule out	< 1.30	NPV ~90%	F0–F2 (no/mild/moderate fibrosis)	Lifestyle care; annual LFTs + CBC
Indeterminate	1.30 to 2.67	Cannot exclude F3–F4	F1–F3 possible (~20–30% of patients)	FibroScan; NFS; hepatology referral
Rule in	> 2.67 (> 2.0 if age ≥65)	PPV ~65–80%	F3–F4 (bridging fibrosis/cirrhosis)	Urgent specialist evaluation

FIB-4 was originally validated in HCV cohorts (Sterling et al. 2006) and subsequently validated in NAFLD, HBV, and mixed liver disease populations. It performs best at the extremes—indeterminate scores need elastography or NFS for concordant staging.

Understanding NAFLD, MASLD & NASH — Disease Progression

NAFLD (non-alcoholic fatty liver disease) is now often termed MASLD (metabolic dysfunction-associated steatotic liver disease). Simple steatosis is fat accumulation without significant inflammation—often reversible. NASH/MASH (steatohepatitis) adds inflammation and hepatocyte injury. Untreated, NASH can progress through fibrosis stages to cirrhosis and hepatocellular carcinoma. FIB-4 screens for advanced fibrosis (F3–F4) across NAFLD, viral hepatitis, and chronic liver disease—not for diagnosing steatosis itself.

Stage	What happens	Reversible?	FIB-4 role
Steatosis (F0)	Fat in liver cells; enzymes may be normal	Yes — lifestyle change	Usually FIB-4 < 1.30
NASH/MASH inflammation	Fat + inflammation; ALT/AST often elevated	Often — with 7–10% weight loss	Variable FIB-4
Fibrosis F1–F2	Early scar tissue in liver	Partially reversible	Low or indeterminate FIB-4
Bridging fibrosis (F3)	Extensive scarring between portal areas	Limited — specialist care	Often FIB-4 > 2.67
Cirrhosis (F4)	End-stage scarring; impaired liver function	Not reversible — prevent progression	High FIB-4; HCC surveillance needed

Understanding Each FIB-4 Lab Variable

AST & ALT

AST sits in the FIB-4 numerator (age × AST), so elevated AST directly raises the score. ALT is in the denominator as √ALT—a lower ALT mathematically increases FIB-4. In simple steatosis, ALT often exceeds AST; as fibrosis advances, AST/ALT ratio ≥ 1.0 becomes a fibrosis signal even though FIB-4 uses them separately.

Typical AST: 10–40 U/L
Typical ALT: 7–56 U/L (men), 7–35 (women)
Muscle injury, alcohol, and statins also raise AST

Platelet count

Platelets are in the FIB-4 denominator—lower counts substantially raise the score. In advanced liver disease, portal hypertension causes splenic sequestration and thrombocytopenia. Low platelets may signal serious liver disease even when other labs look modestly abnormal.

Normal: 150–400 ×10⁹/L
<150 ×10⁹/L: thrombocytopenia — evaluate for fibrosis
Enter as ×10⁹/L or ×10³/µL (same number)

Age

Age is multiplied by AST in the numerator, making FIB-4 naturally higher in older adults independent of fibrosis severity. A 70-year-old with the same AST, ALT, and platelets as a 40-year-old will have nearly twice the FIB-4 score. For adults ≥65, clinicians often use a rule-in cutoff of > 2.0 instead of 2.67 to reduce false positives. Always confirm elevated FIB-4 in older adults with FibroScan or specialist review.

FIB-4 validated in adults 18–100 years
Age-adjusted cutoffs recommended per AASLD guidance in ≥65
Pair with NFS Calculator when metabolic labs available

FIB-4 vs NAFLD Fibrosis Score (NFS) — Which to Use?

Feature	FIB-4 (this calculator)	NFS
Formula	(Age × AST) ÷ (Platelets × √ALT)	Age, BMI, diabetes, AST/ALT, platelets, albumin
Inputs needed	4 values only	7 values (includes BMI, diabetes, albumin)
Validated for	General liver fibrosis (HBV, HCV, NAFLD)	NAFLD/MASLD specifically
Low cutoff	< 1.30 (rule out F3–F4)	< −1.455 (rule out F3–F4)
High cutoff	> 2.67 (rule in F3–F4)	> 0.676 (rule in F3–F4)
Best practice	Use NFS first in NAFLD; if indeterminate, add FIB-4 and FibroScan for concordant staging. FIB-4 is ideal when only basic labs are available.

FibroScan & When FIB-4 Is Indeterminate

Transient elastography (FibroScan) measures liver stiffness in kilopascals (kPa) using ultrasound shear wave—non-invasive and widely available in India (₹3,000–8,000 at most centres). When FIB-4 falls in the indeterminate zone (1.30 to 2.67), FibroScan is the recommended next step per AASLD and EASL guidelines.

FibroScan (kPa)	Fibrosis stage	Clinical meaning
< 7.0	F0–F1	No or mild fibrosis
7.0–9.5	F2	Significant fibrosis
9.5–12.5	F3	Advanced fibrosis
> 12.5	F4	Cirrhosis likely

Symptoms — When Fatty Liver Becomes Serious

Early / often silent

No symptoms in 70–80% of NAFLD cases
Mild fatigue or low energy
Vague right upper abdominal discomfort
Elevated ALT/AST on routine health check-up
Fatty liver found incidentally on ultrasound

Advanced / urgent signs

Unexplained weight loss
Yellow eyes or skin (jaundice)
Abdominal swelling (ascites)
Dark urine, pale stools, easy bruising
Confusion (hepatic encephalopathy) — emergency

High or indeterminate FIB-4 with any advanced symptom warrants same-day medical evaluation—not watchful waiting.

FIB-4 Liver Fibrosis Screening in India

Prevalence: NAFLD/MASLD affects ~25–30% of Indian adults—higher in urban, sedentary populations
Diabetes overlap: ~77 million Indians with diabetes; up to 70% may have coexisting fatty liver
Lower BMI risk: South Asians develop significant hepatic steatosis at BMI ≥23 (Asian overweight cutoff)
Lean NAFLD: 10–20% of cases occur at normal BMI with high waist or poor diet quality
Test costs: LFT panel ₹500–1,500; CBC ₹200–500; FibroScan ₹3,000–8,000 at major diagnostic centres
Silent progression: Most advanced fibrosis is caught on corporate health panels, not from symptoms—FIB-4 helps triage who needs FibroScan
Diet drivers: Refined carbs, fried snacks, sugary beverages, and sedentary desk jobs accelerate fibrosis in Indian adults

Recommended Lab Panel for FIB-4 Calculation

FIB-4 requires only four values, but a broader liver workup helps contextualise results and guides next steps. Ask your doctor for:

Liver function tests (LFTs): AST, ALT, GGT, bilirubin, alkaline phosphatase, albumin, total protein
Complete blood count (CBC): platelet count (required for FIB-4)
Fasting glucose & HbA1c: for metabolic context and NFS comparison if needed
Lipid profile: triglycerides and HDL often elevated in MASLD
Abdominal ultrasound: confirms hepatic steatosis if not already done
FibroScan: if FIB-4 is indeterminate or high

Pair with our Triglyceride/HDL Ratio Calculator, Cholesterol Risk Calculator, and BUN/Creatinine Ratio Calculator for broader metabolic and kidney assessment.

Diet & Weight Loss to Improve FIB-4 Over Time

Sustained lifestyle change is the only proven intervention that reverses early fibrosis. Clinical trials show 7–10% body weight loss reduces liver fat, normalises enzymes, and can lower FIB-4 over 6–12 months.

Mediterranean pattern: olive oil, fish, legumes, vegetables, whole grains
Cut fructose: soft drinks, packaged juices, excess sweet chai, mithai
Limit fried food: samosas, pakoras, restaurant deep-fried items
Increase fibre: dal, vegetables, millets (jowar, bajra)

150+ min/week aerobic exercise: brisk walking, cycling, swimming
Resistance training: 2×/week preserves muscle during weight loss
Zero alcohol during active fibrosis management
Recheck FIB-4 6–12 months after sustained lifestyle change

Medications & Conditions That Affect FIB-4 Inputs

May raise AST/ALT

Statins (usually mild, often continue safely)
Methotrexate, amiodarone, isoniazid
Paracetamol overdose
Strenuous exercise before blood draw
Non-alcoholic and alcoholic hepatitis flares

May lower platelets

Portal hypertension (advanced fibrosis)
Malnutrition, chronic illness
Chemotherapy (bone marrow suppression)
Autoimmune thrombocytopenia (unrelated to liver)
Viral infections affecting bone marrow

Always interpret FIB-4 with your medication list and symptom timeline. Repeat abnormal labs after resolving acute illness before staging decisions.

MASH Treatment Options When Fibrosis Is Confirmed

Resmetirom (Rezdiffra): FDA-approved for MASH with F2–F3 fibrosis; hepatology-prescribed only
GLP-1 agonists: semaglutide, tirzepatide — weight loss plus emerging fibrosis benefits in trials
Pioglitazone: evidence in selected nondiabetic and diabetic NASH patients (specialist decision)
Vitamin E: non-diabetic NASH with biopsy-proven steatohepatitis (declining first-line use)
Bariatric surgery: considered for BMI ≥35 with failed lifestyle intervention and significant fibrosis

Never start or stop liver medications based solely on calculator results. All pharmacotherapy requires hepatologist guidance after proper staging.

Common FIB-4 Mistakes to Avoid

1. Ignoring age-related elevation

Age is in the FIB-4 numerator. Patients ≥65 often score higher even without advanced fibrosis—use the age-adjusted rule-in cutoff of > 2.0 and confirm with FibroScan.

2. Using ALT = 0 or missing platelets

ALT must be > 0 for √ALT in the denominator. Platelets must be from the same blood draw as liver enzymes for accurate staging.

3. Ignoring indeterminate scores

~20–30% of patients fall in the indeterminate zone. Do not assume mild disease—request FibroScan, NFS comparison, or hepatology referral rather than repeating FIB-4 alone.

4. Treating low FIB-4 as a "healthy liver" guarantee

Low FIB-4 excludes advanced fibrosis but not steatosis, inflammation, or early F1–F2 fibrosis. Continue lifestyle optimisation and periodic enzyme monitoring.

5. Using FIB-4 without confirmed liver disease context

FIB-4 stages fibrosis in patients with known or suspected chronic liver disease—not for general population screening. Confirm steatosis on ultrasound first, or use our Fatty Liver Risk Calculator for initial lifestyle screening.

6. Applying FIB-4 during heavy alcohol use

Heavy alcohol (>14 units/week) elevates AST independently and invalidates fibrosis score interpretation—evaluate for alcoholic liver disease overlap with our Alcohol Impact Calculator.

When to Seek Emergency Care

Jaundice (yellow eyes or skin) with high FIB-4
Vomiting blood or black tarry stools
Severe abdominal pain or rapidly enlarging abdomen
Confusion, drowsiness, or personality change (hepatic encephalopathy)
Call 102 or 108 (India ambulance) or go to the nearest emergency department

Frequently Asked Questions (FAQs)

Related Calculators

You might also be interested in these related health and wellness calculators:

Fatty Liver Risk Calculator

Assess NAFLD/MASLD fatty liver risk from BMI, waist, diabetes, diet, alcohol and lifestyle. Get weight-loss targets, diet tips, exercise guidance, and liver test recommendations.

Try Calculator →

NAFLD Fibrosis Score (NFS) Calculator

Calculate the NAFLD Fibrosis Score from age, BMI, diabetes, AST, ALT, platelets and albumin. Screen for advanced liver fibrosis (F3–F4) in NAFLD/MASLD with validated cutoffs and PDF export.

Try Calculator →

Fatty Liver Severity Calculator

Calculate the Hepatic Steatosis Index (HSI) from ALT, AST, BMI, sex and diabetes status. Screen for fatty liver steatosis severity in NAFLD/MASLD with validated cutoffs and PDF export.

Try Calculator →

Metabolic Syndrome Risk Calculator

Screen metabolic syndrome with all 5 harmonized criteria—waist, triglycerides, HDL, blood pressure and fasting glucose. Asian waist cutoffs, diet tips, exercise guidance and lab recommendations.

Try Calculator →

Insulin Resistance (HOMA-IR) Calculator

Calculate HOMA-IR from fasting glucose and fasting insulin to estimate insulin resistance. Get category, HOMA-β, and educational guidance for metabolic health.

Try Calculator →

HbA1c ↔ Average Blood Glucose Calculator

Convert HbA1c (%) to estimated average glucose (eAG) and back using the ADAG formula. ADA category bands, mg/dL and mmol/L units, PDF export.

Try Calculator →

Type 2 Diabetes Risk Assessment Calculator

Assess type 2 diabetes risk using the Indian Diabetes Risk Score (IDRS). Enter age, waist, family history, activity, and clinical history. Low to Very High risk with PDF export.

Try Calculator →

Triglyceride/HDL Ratio Calculator

Calculate triglyceride/HDL ratio from fasting lipids for cardiometabolic risk, insulin resistance screening, AHA lipid interpretation, and PDF export.

Try Calculator →

Calculator Categories

Explore more free tools by health topic. Your calculator's category is highlighted below.

This calculator